Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Danaher Corporation (DHR)

251.8   3.42 (1.38%) 03-22 14:11
Open: 249.38 Pre. Close: 248.38
High: 252.76 Low: 248.6
Volume: 2,194,389 Market Cap: 183,456(M)

Technical analysis

as of: 2023-03-22 1:46:31 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 302.24     One year: 353.02
Support: Support1: 245.31    Support2: 237
Resistance: Resistance1: 258.76    Resistance2: 302.24
Pivot: 246.17
Moving Average: MA(5): 247.22     MA(20): 246.75
MA(100): 259.64     MA(250): 264.33
MACD: MACD(12,26): -2.8     Signal(9): -3.9
Stochastic oscillator: %K(14,3): 62.7     %D(3): 53.5
RSI: RSI(14): 51.1
52-week: High: 303.82  Low: 233.71
Average Vol(K): 3-Month: 2,499 (K)  10-Days: 2,342 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ DHR ] has closed below upper band by 21.2%. Bollinger Bands are 32.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 249.31 - 250.32 250.32 - 251.28
Low: 243.32 - 244.45 244.45 - 245.53
Close: 246.58 - 248.34 248.34 - 250.02

Company Description

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Headline News

Wed, 22 Mar 2023
Guru Fundamental Report for DHR - Peter Lynch - Nasdaq

Tue, 21 Mar 2023
Danaher (DHR) Outpaces Stock Market Gains: What You Should ... - Nasdaq

Tue, 21 Mar 2023
Danaher Corporation - Consensus Indicates Potential 23.5% Upside - DirectorsTalk Interviews

Mon, 20 Mar 2023
Danaher Co. (NYSE:DHR) Receives Average Recommendation of ... - MarketBeat

Sun, 19 Mar 2023
State of Alaska Department of Revenue Raises Holdings in Danaher ... - MarketBeat

Wed, 15 Mar 2023
Is Now The Time To Look At Buying Danaher Corporation (NYSE:DHR)? - Simply Wall St

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. 729 (M)
Shares Float 646 (M)
% Held by Insiders 10.9 (%)
% Held by Institutions 80.6 (%)
Shares Short 3,720 (K)
Shares Short P.Month 4,260 (K)

Stock Financials

EPS 9.68
EPS Est Next Qtl 0.94
EPS Est This Year 3.99
EPS Est Next Year 4.34
Book Value (p.s.) 66.47
Profit Margin (%) 22.9
Operating Margin (%) 27.7
Return on Assets (ttm) 6.5
Return on Equity (ttm) 15.1
Qtrly Rev. Growth 2.7
Gross Profit (p.s.) 26
Sales Per Share 43.19
EBITDA (p.s.) 15.04
Qtrly Earnings Growth 23.8
Operating Cash Flow 8,520 (M)
Levered Free Cash Flow 5,590 (M)

Stock Valuations

PE Ratio 25.86
PEG Ratio 7.5
Price to Book value 3.77
Price to Sales 5.8
Price to Cash Flow 21.43

Stock Dividends

Dividend 0.25
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2022-01-27
Ex-Dividend Date 2021-12-28
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.